» Articles » PMID: 1908189

Misoprostol Attenuates Acetic Acid-induced Increases in Mucosal Permeability and Inflammation: Role of Blood Flow

Overview
Journal Am J Physiol
Specialty Physiology
Date 1991 Aug 1
PMID 1908189
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The objectives of this study were 1) to quantify the effects of misoprostol (Miso; prostaglandin E1 analogue) on acetic acid-induced increases in mucosal permeability and inflammation; 2) to determine what effect acetic acid, Miso, or the combination of Miso plus acetic acid has on colonic blood flow; and 3) to assess whether the protective effect of Miso may be attributable to its vasodilatory properties. We found that intrarectal administration of acetic acid produced a 6.4-fold increase in colonic myeloperoxidase activity (an index of granulocyte infiltration), an 8.2-fold increase in mucosal permeability, a 1.6-fold increase in colonic weight, and a 6.8% decrease in body weight 48 h after enema. Miso pretreatment significantly attenuated the increases in colonic myeloperoxidase activity, mucosal permeability, and colon weight as well as prevented the loss of body weight. In a different series of experiments, we found that blood flow in the descending, transverse, and ascending colon increased 2.5- to 3.5-fold immediately after the acetic acid enema; however, it returned to control values at 1 and 4 h after enema. Miso pretreatment, followed by acetic acid, resulted in a further increase (2.5-fold) in blood flow in the descending colon 1 h after enema compared with acetic acid alone. This Miso-induced increase in blood flow at 1 h could not account for its protective effect inasmuch as colonic mucosal permeability (i.e., injury) in Miso-pretreated animals was not significantly different from values obtained in animals pretreated with vehicle and then given the enema.

Citing Articles

Misoprostol protects mice against severe Clostridium difficile infection and promotes recovery of the gut microbiota after antibiotic perturbation.

Zackular J, Kirk L, Trindade B, Skaar E, Aronoff D Anaerobe. 2019; 58:89-94.

PMID: 31220605 PMC: 6697607. DOI: 10.1016/j.anaerobe.2019.06.006.


Intestinal blood flow in murine colitis induced with dextran sulfate sodium.

Garrelds I, Heiligers J, van Meeteren M, Duncker D, Saxena P, Meijssen M Dig Dis Sci. 2002; 47(10):2231-6.

PMID: 12395896 DOI: 10.1023/a:1020183110468.


Rebamipide, an antiulcer drug, prevents DSS-induced colitis formation in rats.

Kishimoto S, Haruma K, TARI A, Sakurai K, Nakano M, Nakagawa Y Dig Dis Sci. 2000; 45(8):1608-16.

PMID: 11007113 DOI: 10.1023/a:1005525313856.


Temporal patterns of colonic blood flow and tissue damage in an animal model of colitis.

Appleyard C, Williams J, Hathaway C, Percy W Dig Dis Sci. 1999; 44(2):431-8.

PMID: 10063934 DOI: 10.1023/a:1026687424966.


Intracolonic administration of zileuton, a selective 5-lipoxygenase inhibitor, accelerates healing in a rat model of chronic colitis.

Bertran X, Mane J, Fernandez-Banares F, Castella E, Bartoli R, Ojanguren I Gut. 1996; 38(6):899-904.

PMID: 8984030 PMC: 1383199. DOI: 10.1136/gut.38.6.899.